E A Orlova < E A Ottesen < E A Padmasiri

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 46.
[0-20] [0 - 20][0 - 46][20-40]

Ident.	Authors (with country if any)	Title
002A73 (2009)	P J Hooper [États-Unis] ; M H Bradley ; G. Biswas ; E A Ottesen	The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
003E98 (2002)	D D Chadee [Trinité-et-Tobago] ; S A Williams ; E A Ottesen	Xenomonitoring of Culex quinquefasciatus mosquitoes as a guide for detecting the presence or absence of lymphatic filariasis: a preliminary protocol for mosquito sampling.
004070 (2002)	S A Williams [États-Unis] ; S J Laney ; L A Bierwert ; L J Saunders ; D A Boakye ; P. Fischer ; D. Goodman ; H. Helmy ; S L Hoti ; V. Vasuki ; P J Lammie ; C. Plichart ; R M R. Ramzy ; E A Ottesen	Development and standardization of a rapid, PCR-based method for the detection of Wuchereria bancrofti in mosquitoes, for xenomonitoring the human prevalence of bancroftian filariasis.
004142 (2001)	C. Steel [États-Unis] ; E A Ottesen ; P F Weller ; T B Nutman	Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific.
004234 (2001)	C. Witt [Suisse] ; E A Ottesen	Lymphatic filariasis: an infection of childhood.
004238 (2001)	G. Dreyer [Brésil] ; J. Figueredo-Silva ; K. Carvalho ; F. Amaral ; E A Ottesen	Lymphatic filariasis in children: adenopathy and its evolution in two young girls.
004271 (2001)	C. Steel [États-Unis] ; E A Ottesen	Evolution of immunologic responsiveness of persons living in an area of endemic bancroftian filariasis: a 17-year follow-up.
004367 (2000)	E A Ottesen	The global programme to eliminate lymphatic filariasis.
004446 (2000)	K R Brown [États-Unis] ; F M Ricci ; E A Ottesen	Ivermectin: effectiveness in lymphatic filariasis.
004518 (2000)	J. Horton [Royaume-Uni] ; C. Witt ; E A Ottesen ; J K Lazdins ; D G Addiss ; K. Awadzi ; M J Beach ; V Y Belizario ; S K Dunyo ; M. Espinel ; J O Gyapong ; M. Hossain ; M M Ismail ; R L Jayakody ; P J Lammie ; W. Makunde ; D. Richard-Lenoble ; B. Selve ; R K Shenoy ; P E Simonsen ; C N Wamae ; M V Weerasooriya	An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
004571 (1999)	E A Ottesen [Suisse] ; M M Ismail ; J. Horton	The role of albendazole in programmes to eliminate lymphatic filariasis.
004836 (1998)	A L Vincent [États-Unis] ; C A Ure A Rojas ; E M Ayoub ; E A Ottesen ; E G Harden	Filariasis and erisipela in Santo Domingo.
004943 (1997)	E A Ottesen [Suisse] ; B O Duke ; M. Karam ; K. Behbehani	Strategies and tools for the control/elimination of lymphatic filariasis.
004B61 (1996)	S. Mahanty [États-Unis] ; S N Mollis ; M. Ravichandran ; J S Abrams ; V. Kumaraswami ; K. Jayaraman ; E A Ottesen ; T B Nutman	High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis.
004B71 (1996)	C. Steel [États-Unis] ; A. Guinea ; E A Ottesen	Evidence for protective immunity to bancroftian filariasis in the Cook Islands.
004B98 (1996)	M. Zhong [États-Unis] ; J. Mccarthy ; L. Bierwert ; M. Lizotte-Waniewski ; S. Chanteau ; T B Nutman ; E A Ottesen ; S A Williams	A polymerase chain reaction assay for detection of the parasite Wuchereria bancrofti in human blood samples.
004E50 (1994)	C. Steel [États-Unis] ; A. Guinea ; J S Mccarthy ; E A Ottesen	Long-term effect of prenatal exposure to maternal microfilaraemia on immune responsiveness to filarial parasite antigens.
004E59 (1994)	J P Moulia-Pelat [Polynésie française] ; L N Nguyen ; P. Glaziou ; S. Chanteau ; E A Ottesen ; R. Cardines ; P M Martin ; J L Cartel	Ivermectin plus diethylcarbamazine: an additive effect on early microfilarial clearance.
004E62 (1994)	P F Turner [Australie] ; K A Rockett ; E A Ottesen ; H. Francis ; K. Awadzi ; I A Clark	Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis.
005017 (1993)	A P Limaye [États-Unis] ; E A Ottesen ; V. Kumaraswami ; J S Abrams ; J. Regunathan ; V. Vijayasekaran ; K. Jayaraman ; T B Nutman	Kinetics of serum and cellular interleukin-5 in posttreatment eosinophilia of patients with lymphatic filariasis.
005043 (1993)	C L King [États-Unis] ; S. Mahanty ; V. Kumaraswami ; J S Abrams ; J. Regunathan ; K. Jayaraman ; E A Ottesen ; T B Nutman	Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "E A Ottesen" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "E A Ottesen" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    E A Ottesen
}}

---

This area was generated with Dilib version V0.6.31. Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024